Deakin University
Browse

File(s) under permanent embargo

A review of clozapine safety

journal contribution
posted on 2005-07-01, 00:00 authored by J Fitzsimons, Michael BerkMichael Berk, T Lambert, M Bourin, Seetal DoddSeetal Dodd
Clozapine is a distinctive antipsychotic agent, having a unique clinical profile and an idiosyncratic safety profile. More so than with other agents, the weighting of its adverse event profile is critical, in order to counterbalance its clear clinical advantages. The safety issues with clozapine are in a number of areas, some of which are considered medical emergencies and potentially life-threatening. These include haematological (neutropenia and agranulocytosis), CNS (seizures), cardiovascular (myocarditis and cardiomyopathy), metabolic (diabetes), gastrointestinal and neuromuscular. Understanding the safety profile of clozapine allows an informed use of the agent that can maximise its clear clinical benefit and minimise the known risks.

History

Journal

Expert opinion on drug safety

Volume

4

Issue

4

Pagination

731 - 744

Publisher

Informa Healthcare

Location

London, England

ISSN

1474-0338

eISSN

1744-764X

Language

eng

Publication classification

C1.1 Refereed article in a scholarly journal

Copyright notice

2005, Informa Healthcare

Usage metrics

    Research Publications

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC